The Origins of Ultrasound Therapy

Ultrasound technology originated from the 18th-century investigations of physiologist Lazzaro Spallanzani. His insights into bat echolocation became the cornerstone for current ultrasound therapy applications. Initially serving as an object detection tool, the medical use of ultrasound emerged in the early 20th century to assist athletes and arthritis patients. It soon established itself in the realm of medical diagnosis.

A detailed study named "A Comprehensive Review of Ineffectiveness of Therapeutic Ultrasound" was undertaken by Velama J Robertson and Kerry G Baker. They deduced:

“… Therapeutic ultrasound ranks among the most ubiquitous and recurrent electrophysical agents. Despite being in clinical use for more than six decades, the efficacy of ultrasound in treating individuals with pain, musculoskeletal injuries, and soft tissue lesions remains uncertain."

​

CureMed's Unique Proposition

CureMed sets itself apart from traditional ultrasound devices. While conventional ultrasound machines provide temporary relief by heating the skin and the muscle beneath, CureMed offers an innovative solution. By synergizing ultrasound with Electric Field Stimulation (EFS), it is the only device worldwide capable of overcoming skin impedance to access blood vessels up to 7cm below the skin's surface. Its vortex-like action helps unclog these vessels, contributing to the restoration of natural and healthy circulation.

​

Understanding CureMed's Function

CureMed offers a practical, non-invasive, and efficient means to convert unhealthy circulatory and lymphatic systems into robust and effective ones. It achieves this by enhancing blood circulation and purging inflammatory mediators from injured tissues, naturally alleviating pain.

CureMed's treatment modality is underpinned by an innovative blend of Electric Field Stimulation and ultrasound. Together, they surmount skin impedance to stimulate blood vessel function, amplify blood flow, and promote recovery and regeneration of damaged tissues.

Unlike typical interventions involving antidepressants, anti-epileptics, and opioids, which only provide fleeting pain relief, CureMed addresses the root cause — efficiently mitigating pain and fostering tissue recovery with sustained results and no side effects.

​

A Strategic Market Advantage

Today's pain treatment landscape conveys a glaring gap — no long-term and effective treatment exists for Nerve Entrapment Syndrome. Doctors typically prescribe narcotics for brief pain alleviation or resort to surgery, which may either worsen or improve the condition.

Companies claiming extended pain reduction periods or lower pain levels often face rejection from these physicians. The rationale is simple: introducing a new treatment into a clinic demands significant effort, particularly when the benefits are slight and fleeting.

This is where CureMed emerges as a game-changer. The potential of CureMed's enduring solutions for conditions like Carpal Tunnel Syndrome or a Slipped Disc immediately captivates clinics. It represents a long-awaited advancement in pain management, and clinics are likely to exert the necessary effort to integrate it, considering the substantial benefits it promises.